ParkerVision, Inc. (OTCQB:PRKR) filed an opening brief with the U.S. Court of Appeals for the Federal Circuit on February 5, 2026, seeking an expedited review of a May 2025 district court decision that added a “generating limitation” to the company’s receiver‑patent claims and resulted in a summary judgment of non‑infringement.
The brief challenges the district court’s claim construction, arguing that the limitation was inconsistent with prior Federal Circuit rulings and that it effectively rendered the claims meaningless. The court had granted an expedited schedule in October 2025, suspended it when Qualcomm moved to dismiss, and reinstated the expedited timeline on January 21, 2026, allowing ParkerVision to file the brief within the shortened window.
ParkerVision’s business model is almost entirely built on patent enforcement and licensing. In the first half of 2023 the company generated $25 million in revenue from license agreements and settlements and posted a net income of $14.5 million. By 2024 it reported a net loss of $14.5 million, and in the first half of 2025 it recorded zero revenue, underscoring its dependence on litigation outcomes for cash flow and survival.
The potential damages at stake are substantial. An expert report estimates that a favorable ruling could yield up to $2.6 billion in damages, a figure that would dwarf the company’s historical earnings and could provide the capital needed to sustain operations and fund future litigation.
ParkerVision is not only fighting Qualcomm. The company has active infringement suits against MediaTek, Realtek, Texas Instruments and NXP Semiconductors, with trials scheduled for late 2025 and early 2026. These cases collectively represent a significant portion of the company’s projected revenue stream.
CEO Jeffrey Parker said the expedited schedule “gives us a chance to correct a critical error in the district court’s claim construction and to preserve the possibility of a substantial award.” He added that a reversal would “enable the case to proceed to trial, where the company can seek the damages and licensing revenue that are essential to its continued operation.”
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.